Millennium Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
Millennium Management's MTRI Position: Q4 2022 in Review
Millennium Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2022, closing a stake of 70 shares — an estimated $91K sold.
Millennium Management first reported a position in MTRI in Q1 2022 and held it in 2 quarters. The position peaked at $91K in Q3 2022. 3 funds tracked by Wall St. Rank hold MTRI as of Q4 2022.
- Millennium Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Millennium Management sold 70 Mentari Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $91K.
- Millennium Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
- Millennium Management's Mentari Therapeutics, Inc. Common Stock position peaked at $91K in Q3 2022.
- 3 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2022.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.